Ca2+Channel Subtypes and Pharmacology in the Kidney
Authors:
- 16 February 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 100 (3) , 342-353
Abstract
A large body of evidence has accrued indicating that voltage-gated Ca2+channel subtypes, including L-, T-, N-, and P/Q-type, are present within renal vascular and tubular tissues, and the blockade of these Ca2+channels produces diverse actions on renal microcirculation. Because nifedipine acts exclusively on L-type Ca2+channels, the observation that nifedipine predominantly dilates afferent arterioles implicates intrarenal heterogeneity in the distribution of L-type Ca2+channels and suggests that it potentially causes glomerular hypertension. In contrast, recently developed Ca2+channel blockers (CCBs), including mibefradil and efonidipine, exert blocking action on L-type and T-type Ca2+channels and elicit vasodilation of afferent and efferent arterioles, which suggests the presence of T-type Ca2+channels in both arterioles and the distinct impact on intraglomerular pressure. Recently, aldosterone has been established as an aggravating factor in kidney disease, and T-type Ca2+channels mediate aldosterone release as well as its effect on renal efferent arteriolar tone. Furthermore, T-type CCBs are reported to exert inhibitory action on inflammatory process and renin secretion. Similarly, N-type Ca2+channels are present in nerve terminals, and the inhibition of neurotransmitter release by N-type CCBs (eg, cilnidipine) elicits dilation of afferent and efferent arterioles and reduces glomerular pressure. Collectively, the kidney is endowed with a variety of Ca2+channel subtypes, and the inhibition of these channels by their specific CCBs leads to variable impact on renal microcirculation. Furthermore, multifaceted activity of CCBs on T- and N-type Ca2+channels may offer additive benefits through nonhemodynamic mechanisms in the progression of chronic kidney disease.Keywords
This publication has 137 references indexed in Scilit:
- Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel α1CsubunitProceedings of the National Academy of Sciences, 2006
- Coexpression of Voltage-Dependent Calcium Channels Cav1.2, 2.1a, and 2.1b in Vascular MyocytesHypertension, 2006
- Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetesClinical and Experimental Nephrology, 2004
- Causes and Consequences of Increased Sympathetic Activity in Renal DiseaseHypertension, 2004
- Aldosterone target organ protection by eplerenoneMolecular and Cellular Endocrinology, 2004
- T-type calcium channels in the regulation of afferent and efferent arterioles in ratsAmerican Journal of Physiology-Renal Physiology, 2004
- Vessel- and Vasoconstrictor-Dependent Role of Rho/Rho-Kinase in Renal Microvascular ToneJournal of Vascular Research, 2003
- Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.Hypertension, 1992
- Renal hemodynamic effects of calcium antagonists in rats with reduced renal mass.Hypertension, 1991
- Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs.Hypertension, 1983